Hunter syndrome synonyms

Hunter syndrome, clinically classified as Mucopolysaccharidosis type II (MPS II), is a rare X-linked genetic disorder caused by a deficiency of the enzyme iduronate-2-sulfatase. While frequently referred to as Hunter syndrome in clinical practice, it is officially recognized in medical literature as MPS II to reflect its classification within the broader group of mucopolysaccharide storage diseases.

What are the common synonyms and historical names for Hunter syndrome?

In medical records and historical texts, you may encounter various terms for Hunter syndrome. The most common alternative names include:

• Mucopolysaccharidosis type II (MPS II)


• Iduronate-2-sulfatase deficiency


• MPS II


• Sulfoiduronate sulfatase deficiency

Historically, the condition was named after Dr. Charles Hunter, who first described the clinical features in 1917. In older medical literature, you might occasionally see it referred to as "MPS II-A" or "MPS II-B," which were older attempts to categorize the condition based on the presence or absence of neurological involvement.

Why does Hunter syndrome have multiple names?

The naming of Hunter syndrome reflects the evolution of medical diagnostics. Early researchers often named diseases after the physicians who first identified them (eponyms), such as Dr. Charles Hunter. As our understanding of biochemical pathways grew, the medical community shifted toward descriptive names like Mucopolysaccharidosis type II, which identifies the underlying metabolic defect. Today, Hunter syndrome remains the most commonly used term by patients and clinicians, while MPS II is the standard for formal diagnostic and insurance coding.

How is Hunter syndrome classified in medical systems?

To ensure consistency, international health organizations use standardized codes for Hunter syndrome:

• OMIM (Online Mendelian Inheritance in Man): #309900


• Orphanet: ORPHA602


• ICD-10: E76.21

Next steps

• Consult a metabolic geneticist to confirm your specific subtype of Hunter syndrome.


• Join the 66 members of the DiseaseMaps.org community to share experiences with others living with Hunter syndrome.


• Visit the National MPS Society website for the latest updates on enzyme replacement therapies and clinical trials.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hunter syndrome (MPS II)


• Orphanet: Mucopolysaccharidosis type II


• OMIM: #309900 Mucopolysaccharidosis type II


• National MPS Society: Understanding MPS II